RAPP Stock Tempers Premarket Gains On Concerns Over Higher Discontinuation Rates In Bipolar Mania Study
RAPP Stock Tempers Premarket Gains On Concerns Over Higher Discontinuation Rates In Bipolar Mania Study Stocktwits
Covered in this story
Call it yourself
No calls on $RAPP yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Rapport Therapeutics Inc →Summary aggregated from Stocktwits's public RSS feed. The full reporting belongs to Stocktwits — please read it on their site.